| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 9.6% | $255,643,283 | 7,158,871 | The Vanguard Group | 31 Dec 2024 | |||
| Hudson Bay Capital Management LP | 5.2% | $181,882,793 | 3,936,857 | Hudson Bay Capital Management LP | 30 Jun 2025 | |||
| Deep Track Capital, LP | 4.6% | $123,583,597 | 3,460,756 | Deep Track Capital, LP | 31 Dec 2024 | |||
| FMR LLC | 1.7% | $44,936,964 | 1,258,386 | FMR LLC | 30 Apr 2025 | |||
| GOLDMAN SACHS GROUP INC | 0% | -93% | $6,203 | -$198,951,008 | 132 | -100% | THE GOLDMAN SACHS GROUP, INC. | 30 Sep 2025 |
As of 30 Sep 2025, 4 institutional investors reported holding 45,321 shares of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX). This represents 0.06% of the company’s total 75,607,738 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 45,321 | $2,391,055 | -$3,523,805,727 | $46.99 | 4 |
| 2025 Q2 | 75,052,336 | $3,527,065,482 | +$108,735,088 | $46.99 | 221 |
| 2025 Q1 | 73,697,303 | $3,254,808,978 | -$236,161,841 | $44.13 | 304 |
| 2024 Q4 | 80,834,506 | $2,920,603,173 | -$109,766,205 | $36.13 | 213 |
| 2024 Q3 | 80,482,008 | $2,579,248,688 | +$40,267,040 | $32.04 | 223 |
| 2024 Q2 | 77,074,142 | $2,903,665,346 | -$72,378,093 | $37.67 | 205 |
| 2024 Q1 | 77,858,885 | $3,832,306,855 | +$155,078,903 | $49.22 | 213 |
| 2023 Q4 | 57,820 | $2,119,532 | +$129,904 | $36.87 | 2 |
| 2023 Q3 | 67,937,000 | $1,567,708,711 | -$32,537,905 | $23.12 | 142 |
| 2023 Q2 | 69,319,235 | $1,814,106,196 | +$82,630,830 | $26.22 | 137 |
| 2023 Q1 | 66,228,435 | $1,701,343,042 | -$5,032,018 | $25.74 | 144 |
| 2022 Q4 | 66,452,736 | $1,724,997,650 | +$69,500,620 | $26.01 | 134 |
| 2022 Q3 | 63,248,430 | $1,798,421,682 | +$224,329,656 | $28.53 | 141 |
| 2022 Q2 | 55,265,262 | $1,361,242,986 | +$58,448,315 | $24.62 | 135 |
| 2022 Q1 | 49,154,429 | $2,774,763,179 | +$222,688,221 | $56.44 | 127 |
| 2021 Q4 | 45,250,996 | $2,805,202,022 | +$24,634,072 | $61.98 | 138 |
| 2021 Q3 | 44,912,255 | $2,850,523,672 | +$37,868,788 | $63.44 | 138 |
| 2021 Q2 | 44,646,702 | $3,679,447,030 | +$71,033,057 | $82.41 | 131 |
| 2021 Q1 | 43,628,346 | $3,210,094,190 | +$40,512,165 | $73.57 | 132 |
| 2020 Q4 | 42,788,014 | $3,103,439,098 | +$398,643,892 | $72.52 | 120 |
| 2020 Q3 | 37,392,468 | $1,782,492,599 | +$126,948,167 | $47.67 | 87 |
| 2020 Q2 | 34,736,775 | $1,458,940,432 | +$81,755,790 | $42.00 | 76 |
| 2020 Q1 | 32,985,223 | $890,602,797 | +$24,728,461 | $27.00 | 68 |
| 2019 Q4 | 31,922,184 | $1,228,678,977 | +$27,775,879 | $38.49 | 56 |
| 2019 Q3 | 31,217,200 | $676,785,000 | +$676,784,524 | $21.68 | 43 |
| 2019 Q2 | 53,948 | $4,446,000 | $0 | $82.41 | 1 |
| 2019 Q1 | 53,948 | $4,446,000 | $0 | $82.41 | 1 |